Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Dominder Kaur"'
Publikováno v:
Haemophilia
Introduction In the era of electronic medical records, pen-and-paper-based physician-administered bleeding assessment tools (BAT) remain under-utilized in the clinical setting, as they are noted to be time-consuming. Aim The current study reviews the
Autor:
Lia N Phillips, Dominder Kaur, N. Valerio Dorrello, Larisa Broglie, Jovana Pavisic, Nobuko Hijiya
Publikováno v:
Blood Advances
Key Points Standard chemotherapy can still be used for new diagnosis of acute lymphoblastic leukemia in patients with SARS-CoV-2. Corticosteroid can be given safely to patients with SARS-CoV-2 presenting with acute respiratory distress syndrome and A
Autor:
Dominder Kaur, Jugpal S. Arneja, Christof Senger, Kate Chipperfield, Joseph Lam, Sylvia Cheng
Publikováno v:
Pediatric bloodcancer. 69(9)
Publikováno v:
Journal of Thrombosis and Haemostasis. 18:604-608
Background Evidence-based guidelines recommend that von Willebrand factor (VWF) levels be obtained in the third trimester of pregnancy to facilitate peripartum planning for women with von Willebrand disease (VWD). Objectives To identify the frequency
Autor:
Dominder Kaur, Bryce A. Kerlin
Publikováno v:
Management of Bleeding Patients ISBN: 9783030563370
The interaction of platelets and coagulation proteins with subendothelial collagen at site of vessel injury is an essential part of the hemostatic pathway. For this reason, bleeding is common in some connective tissue disorders wherein the collagen p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d6be64f2cd0a0ab093f56d367351063
https://doi.org/10.1007/978-3-030-56338-7_20
https://doi.org/10.1007/978-3-030-56338-7_20
Autor:
Dominder Kaur, Sarah H. O'Brien
Publikováno v:
Pediatric Bleeding Disorders ISBN: 9783030316600
Acquired von Willebrand disease (AVWD) is a defect of coagulation occurring secondary to other pathologies, leading to abnormal von Willebrand factor (VWF) function. Multiple pathophysiological mechanisms are implicated, and broadly, these are catego
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::69f770b79e3c5aa707d85a0f024a6811
https://doi.org/10.1007/978-3-030-31661-7_12
https://doi.org/10.1007/978-3-030-31661-7_12
Autor:
Dominder Kaur, Sarah H. O'Brien
Publikováno v:
Pediatric Bleeding Disorders ISBN: 9783030316600
Type 2 von Willebrand disease (VWD) is caused by qualitative defects of von Willebrand factor (VWF). It is further divided into four subtypes (2A, 2B, 2M, 2N), based on underlying defect. The bleeding symptoms are primarily mucocutaneous for subtypes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e35acab2d4440613a756a3d1ebca0ba9
https://doi.org/10.1007/978-3-030-31661-7_10
https://doi.org/10.1007/978-3-030-31661-7_10
Autor:
Dominder Kaur, Sarah H. O'Brien
Publikováno v:
Pediatric Bleeding Disorders ISBN: 9783030316600
Von Willebrand disease (VWD) is a defect of the primary hemostatic pathway that results from quantitative or qualitative deficiencies of the von Willebrand factor (VWF). Type 1 VWD is the commonest form and occurs due to reduced level of VWF protein.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ae742509f507ed85539cc9a8b7c2721
https://doi.org/10.1007/978-3-030-31661-7_9
https://doi.org/10.1007/978-3-030-31661-7_9
Autor:
Dominder Kaur, Sarah H. O'Brien
Publikováno v:
Pediatric Bleeding Disorders ISBN: 9783030316600
Type 3 von Willebrand disease (VWD) is a severe quantitative deficiency of von Willebrand factor (VWF) that results in negligible circulating factor levels. As VWF is the carrier protein for factor VIII (FVIII), there is an accompanying FVIII deficie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c17b0893d9c7cff37410f03fcae715ba
https://doi.org/10.1007/978-3-030-31661-7_11
https://doi.org/10.1007/978-3-030-31661-7_11
Autor:
Kent R. Bailey, Shakila P. Khan, Rajiv K. Pruthi, Aneel A. Ashrani, Dominder Kaur, Vilmarie Rodriguez
Publikováno v:
Thrombosis research. 167
Background Overall incidence of hemostatic complications in pediatric recipients of Hematopoietic Stem Cell Transplant (HSCT) is scarcely studied. This retrospective review explored the incidence and underlying risk factors of bleeding and thrombotic